Prevalence of arterial hypertension and its morbidity in children and adolescents 3 years after renal transplantation with mycophenolate mofetil-based immunosuppression

By Jungraithmayr T.   Staskewitz A.   Kirste G.   Boswald M.   Bulla M.   Burghard R.   Dippell J.   Greiner C.   Klare B.   Klaus G.   Leichter H.   Misselwitz J.   Patzer L.   Querfeld U.   Rascher W.   Tonshoff B.   Wiesel M.   Brandis M.   Zimmerhackl L.B.   MMF Study Group  

Transplantation Proceedings, Vol. 34, Iss. 6, 2002-09 ,pp. : 2215-2215

Elsevier

Access to resources Recommend Favorite

Tacrolimus/Mycophenolate Mofetil/Steroid-Based Immunosuppression After Pancreas-Kidney Transplantation With Single Shot Antithymocyte Globulin

By Schulz T.   Martin D.   Heimes M.   Klempnauer J.   Buesing M.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1533-1535

Elsevier

Access to resources Recommend Favorite

Mycophenolate Mofetil as Maintenance Immunosuppression in Pediatric Renal Transplantation

By Ettenger R.   Cohen A.   Nast C.   Moulton L.   Marik J.   Gales B.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 340-341

Elsevier

Access to resources Recommend Favorite

Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation

By Wuthrich R.P.   Weinreich T.   Schwarzkopf A.K.   Candinas D.   Binswanger U.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4096-4097

Elsevier

Access to resources Recommend Favorite

Rejection rate in living donor kidney transplantation with and without basiliximab in tacrolimus/mycophenolate mofetil-based protocol

By Rahamimov R.   Yussim A.   After T.   Lustig S.   Bar-Nathan N.   Shaharabani E.   Shapira Z.   Shabthai E.   Mor E.  

Transplantation Proceedings, Vol. 35, Iss. 2, 2003-03 ,pp. : 653-654

Elsevier

Access to resources Recommend Favorite